UiPath (PATH) Stock
Key stats
- Market cap
- $5.71B
- Price / Earnings ratio
- 16.2x
- EPS (TTM)
- $0.67
- Volume
- Loading
- 52-week high
- $19.84
- 52-week low
- $9.20
- EPS vs analyst estimate
- +6.7%Q3 FY26 · $0.16 vs $0.15
- Next earnings report
- 2 Dec 2026
Source: third-party data provider, as of November 22, 2026
EPS estimate: analyst consensus
Compare with PATH
Recent news

UiPath's ARR Nears $2 Billion: Can It Sustain the Growth Momentum?
UiPath's ARR Nears $2 Billion: Can It Sustain the Growth Momentum?
PATH

ServiceNow vs. UiPath: Which Technology Stock Is a Better Buy for 2027?
ServiceNow vs. UiPath: Which Technology Stock Is a Better Buy for 2027?
PATH

Axon Enterprise vs. UiPath: Which Industrials Stock Is a Better Buy for 2027?
Axon Enterprise vs. UiPath: Which Industrials Stock Is a Better Buy for 2027?
PATH

UiPath vs. Palantir Technologies: Comparing Modest Revenue Growth vs. Rapid Expansion
UiPath vs. Palantir Technologies: Comparing Modest Revenue Growth vs. Rapid Expansion
PATH
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 25.74
- MACD 12/26/9
- -0.51
- EMA 9 of MACD
- -0.28
- MACD histogram
- -0.23
- SMA 50
- $13.20
- Price below SMA 50
- EMA 50
- $13.23
- Price below EMA 50
- SMA 200
- $12.31
- Price below SMA 200
- EMA 200
- $13.01
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 20, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 13 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
Analyst consensus EPS estimate for Q3 FY27: $0.06. The next earnings report is expected on 2 Dec 2026.
Source: third-party data provider
Latest news

UiPath's ARR Nears $2 Billion: Can It Sustain the Growth Momentum?
UiPath's ARR Nears $2 Billion: Can It Sustain the Growth Momentum?
PATH

ServiceNow vs. UiPath: Which Technology Stock Is a Better Buy for 2027?
ServiceNow vs. UiPath: Which Technology Stock Is a Better Buy for 2027?
PATH

Axon Enterprise vs. UiPath: Which Industrials Stock Is a Better Buy for 2027?
Axon Enterprise vs. UiPath: Which Industrials Stock Is a Better Buy for 2027?
PATH

UiPath vs. Palantir Technologies: Comparing Modest Revenue Growth vs. Rapid Expansion
UiPath vs. Palantir Technologies: Comparing Modest Revenue Growth vs. Rapid Expansion
PATH

UiPath (PATH) Declines More Than Market: Some Information for Investors
UiPath (PATH) Declines More Than Market: Some Information for Investors
PATH

Is Trending Stock UiPath, Inc. (PATH) a Buy Now?
Is Trending Stock UiPath, Inc. (PATH) a Buy Now?
PATH

Fastly vs. UiPath: Which Artificial Intelligence Stock Is a Better Buy Going into 2027?
Fastly vs. UiPath: Which Artificial Intelligence Stock Is a Better Buy Going into 2027?
PATH

UiPath (PATH) Declines More Than Market: Some Information for Investors
UiPath (PATH) Declines More Than Market: Some Information for Investors
PATH

UiPath Joins Google Cloud's Gemini For Healthcare As Launch Partner — Enables AI-Powered Workflow Automation
UiPath Joins Google Cloud's Gemini For Healthcare As Launch Partner — Enables AI-Powered Workflow Automation
PATH

UiPath Accelerates Enterprise AI Transformation with Google Cloud's Gemini for Healthcare
UiPath Accelerates Enterprise AI Transformation with Google Cloud's Gemini for Healthcare
PATH
News tone: automated (AI) classification of the article's content, not a price prediction.
About UiPath
UiPath has a vision to deliver the fully automated enterprise™, one where companies use automation to unlock their greatest potential. UiPath offers an end-to-end platform for automation, combining the leading Robotic Process Automation (RPA) solution with a full suite of capabilities that enable every organization to rapidly scale digital business operations.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel Solomon Dines | Co-Founder, CEO, & Executive Chairman of the Board | 1972 |
| Mr. Ashim Gupta | Chief Operating Officer | 1979 |
| Mr. Hitesh Ramani | CFO, Chief Accounting Officer Principal Financial & Accounting Officer | 1978 |
| Mr. Brad C. Brubaker J.D. | Chief Administrative Officer, General Counsel, Chief Legal Officer & Secretary | 1964 |
| Mr. Raghavendra Malpani | Chief Product & Technology Officer | 1978 |
| Ms. Allise Furlani | Senior Director of Investor Relations | — |
| Mr. Michael Atalla | Chief Marketing Officer | — |
| Agi Garaba | Chief People Officer | — |
| Mr. Brandon Deer | Chief Strategy Officer | — |
| Mr. Mark Gibbs | Senior VP & MD of EMEA | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 22, 2026
Technical indicators
- RSI 14
- 25.74
- MACD 12/26/9
- -0.51
- EMA 9 of MACD
- -0.28
- MACD histogram
- -0.23
- SMA 50
- $13.20
- Price below SMA 50
- EMA 50
- $13.23
- Price below EMA 50
- SMA 200
- $12.31
- Price below SMA 200
- EMA 200
- $13.01
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 20, 2026. Technical data, not a recommendation.
Analyst views
13 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $10.00
- Average
- $15.62
- High
- $23.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.3 | -1.8 | ||||||||||
| 2022 | -16.7 | -6.5 | -36.4 | -19.6 | -8.1 | +8.1 | -2.0 | -12.3 | -22.0 | -0.8 | +1.1 | -1.6 |
| 2023 | +25.0 | -13.2 | +20.4 | -19.0 | +26.4 | -7.6 | +6.9 | -11.1 | +7.7 | -9.9 | +27.3 | -0.8 |
| 2024 | -3.4 | +2.8 | -4.1 | -14.5 | -36.3 | +6.4 | -5.5 | +9.2 | +1.7 | -0.3 | +13.0 | -12.5 |
| 2025 | +10.0 | -13.4 | -12.4 | +13.7 | +12.0 | +2.5 | -7.4 | +0.1 | +22.8 | +22.1 | -12.7 | +16.1 |
| 2026 | -20.7 | -14.4 | +3.7 | -6.5 | +9.8 | -17.0 | +10.5 | +43.1 | -29.2 | +3.1 | -17.8 |



